These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 4582717

  • 1. Indirect immunofluorescence testing in bullous diseases.
    Trotter MD.
    Br J Dermatol; 1973 Sep; 89(3):237-42. PubMed ID: 4582717
    [No Abstract] [Full Text] [Related]

  • 2. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen.
    Barton DD, Fine JD, Gammon WR, Sams WM.
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):369-73. PubMed ID: 3525621
    [Abstract] [Full Text] [Related]

  • 3. Utilization of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus and certain other dermatoses.
    Int J Dermatol; 1975 Mar; 14(2):83-100. PubMed ID: 1091572
    [No Abstract] [Full Text] [Related]

  • 4. [The application and value of immunofluorescence procedures in dermatology (author's transl)].
    Holubar K.
    Wien Klin Wochenschr; 1974 Jun 14; 86(12):325-30. PubMed ID: 4599929
    [No Abstract] [Full Text] [Related]

  • 5. Studies in bullous diseases. Immunofluorescent serologic tests.
    Peck SM, Osserman KE, Weiner LB, Lefkovits A, Osserman RS.
    N Engl J Med; 1968 Oct 31; 279(18):951-8. PubMed ID: 4300571
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The mechanism of autoimmune cutaneous diseases].
    Jablonska S, Chorzelski T.
    Ann Dermatol Syphiligr (Paris); 1971 Oct 31; 98(4):377-92. PubMed ID: 4945246
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating autoantibodies in skin diseases: a survey and comparison of immunofluorescence (IF) studies.
    Van Joost T.
    Int J Dermatol; 1975 Oct 31; 14(6):379-96. PubMed ID: 1099028
    [No Abstract] [Full Text] [Related]

  • 11. Immunopathology of bullous diseases.
    Jablonska S.
    Ann Clin Res; 1970 Mar 31; 2(1):7-12. PubMed ID: 4912135
    [No Abstract] [Full Text] [Related]

  • 12. Complement activation in bullous skin diseases.
    Jordon RE.
    J Invest Dermatol; 1975 Jul 31; 65(1):162-9. PubMed ID: 50385
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies in pemphigoid.
    Chorzelski T, Jablońska S, Blaszczyk M, Jarzabek M.
    Dermatologica; 1968 Jul 31; 136(5):325-34. PubMed ID: 4873904
    [No Abstract] [Full Text] [Related]

  • 14. Immunogenetic features of some cases of immune-mediated skin diseases.
    Arnett FC.
    J Autoimmun; 1991 Feb 31; 4(1):97-112. PubMed ID: 2031666
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-epidermal antibodies in bullous dermatoses. Clinical and experimental data].
    Thivolet J, Beyvin AJ.
    Bull Soc Fr Dermatol Syphiligr; 1967 Feb 31; 74(3):300-4. PubMed ID: 4863542
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O, Zaw KK, Miyachi Y, Hashimoto T, Tanaka T.
    Br J Dermatol; 1997 Feb 31; 136(2):222-6. PubMed ID: 9068736
    [Abstract] [Full Text] [Related]

  • 20. Studies in cutaneous immunofluorescence. I. The effect of storage time on direct immunofluorescence of skin biopsies from bullous disease and lupus erythematosus.
    Mackie RM, Young H, Campbell IA.
    J Cutan Pathol; 1980 Aug 31; 7(4):236-43. PubMed ID: 7000865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.